Geoffrey G Adams | PubMed Health

PubMed2005

A prospective clinical study of bone augmentation techniques at immediate implants.

The efficacy of combinations of membranes and autogenous bone grafts at immediate implants were compared in a prospective study. Sixty-two consecutively treated patients each received an immediate implant for a single tooth replacement at a maxillary anterior or premolar site. Dimensions of the peri-implant defect at the implant collar were measured as follows: vertical defect height (VDH), horizontal defect depth (HDD) and horizontal defect width (HDW). Each implant randomly received one of five augmentation treatments and were submerged with connective tissue grafts: Group 1 (n=12)--expanded polytetrafluoroethylene membrane only, Group 2 (n=11)--resorbable polylactide/polyglycolide copolymer membrane only, Group 3 (n=13)--resorbable membrane and autogenous bone graft; Group 4 (n=14)--autogenous bone graft only, and Group 5 (n=12)--no membrane and no bone graft control. At re-entry, all groups showed significant reduction in VDH, HDD and HDW. Comparisons between groups showed no significant differences for VDH (mean 75.4%) and HDD (mean 77%) reduction. Significant differences were observed between groups for HDW reduction (range, 34.1-67.3%), with membrane-treated Groups 1, 2 and 3 showing the greatest reduction. In the presence of dehiscence defects of the labial plate, HDW reduction of 66.6% was achieved with membrane use compared with 37.7% without membranes. Over 50% more labial plate resorption occurred in the presence of a dehiscence defect irrespective of the augmentation treatment used. The results indicate that VDH and HDD reduction at defects adjacent to immediate implants may be achieved without the use of membranes and/or bone grafts.

Adult↗

PubMed2003

Leukemia risk associated with low-level benzene exposure.

BACKGROUND: Men who were part of an Australian petroleum industry cohort had previously been found to have an excess of lympho-hematopoietic cancer. Occupational benzene exposure is a possible cause of this excess. METHODS: We conducted a case-control study of lympho-hematopoietic cancer nested within the existing cohort study to examine the role of benzene exposure. Cases identified between 1981 and 1999 (N = 79) were age-matched to 5 control subjects from the cohort. We estimated each subject's benzene exposure using occupational histories, local site-specific information, and an algorithm using Australian petroleum industry monitoring data. RESULTS: Matched analyses showed that the risk of leukemia was increased at cumulative exposures above 2 ppm-years and with intensity of exposure of highest exposed job over 0.8 ppm. Risk increased with higher exposures; for the 13 case-sets with greater than 8 ppm-years cumulative exposure, the odds ratio was 11.3 (95% confidence interval = 2.85-45.1). The risk of leukemia was not associated with start date or duration of employment. The association with type of workplace was explained by cumulative exposure. There is limited evidence that short-term high exposures carry more risk than the same amount of exposure spread over a longer period. The risks for acute nonlymphocytic leukemia and chronic lymphocytic leukemia were raised for the highest exposed workers. No association was found between non-Hodgkin lymphoma or multiple myeloma and benzene exposure, nor between tobacco or alcohol consumption and any of the cancers. CONCLUSIONS: We found an excess risk of leukemia associated with cumulative benzene exposures and benzene exposure intensities that were considerably lower than reported in previous studies. No evidence was found of a threshold cumulative exposure below which there was no risk.

Adult↗